An increased Bax/Bcl‐2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients-Reference-Cited by-同舟云学术

An increased Bax/Bcl‐2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients

Published:2018-08 Issue:7 Volume:6 Page:1074-1081
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterol. j.

Author:

Aghdaei Hamid Asadzadeh¹,Kadijani Azade Amini¹,Sorrentino Dario²³,Mirzaei Alireza⁴,Shahrokh Shabnam¹,Balaii Hedieh¹,Geraci Marco⁵,Zali Mohammad Reza⁶

Affiliation:

1. Basic and Molecular Epidemiology of Gastrointestinal Disorders Research CenterResearch Institute for Gastroenterology and Liver DiseasesShahid Beheshti University of Medical SciencesTehranIran

2. IBD CenterVirginia Tech Carilion School of MedicineRoanokeVAUSA

3. Department of Clinical and Experimental Medical SciencesUniversity of Udine School of MedicineUdineItaly

4. Bone and Joint Reconstruction Research CenterShafa Orthopedic HospitalIran University of Medical SciencesTehranIran

5. Department of Epidemiology and BiostatisticsArnold School of Public HealthUniversity of South CarolinaColumbiaSCUSA

6. Gastroenterology and Liver Diseases Research CenterResearch Institute for Gastroenterology and Liver DiseasesShahid Beheshti University of Medical SciencesTehranIran

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2050640618774637

Reference39 articles.

1. Inflammatory Bowel Disease: Etiology, Pathogenesis and Current Therapy

2. Adverse reactions to biologic agents and their medical management

3. Biological therapies in Crohn’s disease: are they cost-effective? A critical appraisal of model-based analyses

4. Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review

5. Review article: loss of response to anti-TNF treatments in Crohn’s disease

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoplastics induced health risk: Insights into intestinal barrier homeostasis and potential remediation strategy by dietary intervention;Journal of Hazardous Materials;2024-07

2. Jolkinolide B inhibits the progression of hepatocellular carcinoma by regulating Musashi-2 protein;PLOS ONE;2024-04-17

3. An in vitro study elucidating the synergistic effects of aqueous cinnamon extract and an anti-TNF-α biotherapeutic: implications for a complementary and alternative therapy for non-responders;BMC Complementary Medicine and Therapies;2024-03-23

4. Inhibition of PERK Kinase, an Orchestrator of the Unfolded Protein Response (UPR), Significantly Reduces Apoptosis and Inflammation of Lung Epithelial Cells Triggered by SARS-CoV-2 ORF3a Protein;Biomedicines;2023-05-30

5. Vagus nerve stimulation attenuates acute kidney injury induced by hepatic ischemia/reperfusion injury in rats;Scientific Reports;2022-12-15